-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Solventum, Raises Price Target to $110

Benzinga·11/06/2026 14:27:29
Listen to the news
Piper Sandler analyst Jason Bednar reiterates Solventum (NYSE:SOLV) with a Overweight and raises the price target from $105 to $110.